Ownership history in BAROMETER CAPITAL MANAGEMENT INC. · 8 quarters on record
This page tracks every 13F SEC filing in which BAROMETER CAPITAL MANAGEMENT INC. reported a position in Ascendis Pharma A/S (ASND). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 91,392 | +87,488 | +2241.0% | 2.61% | $10.8M | $213.24 |
| 2025 Q3 | ADDED | 3,904 | +2,900 | +288.8% | 0.18% | $776K | $198.81 |
| 2025 Q2 | UNCHANGED | 1,004 | — | 0% | 0.05% | $173K | $172.60 |
| 2025 Q1 | UNCHANGED | 1,004 | — | 0% | 0.06% | $156K | $155.86 |
| 2024 Q3 | UNCHANGED | 1,004 | — | 0% | 0.04% | $150K | $149.31 |
| 2024 Q2 | REDUCED | 1,004 | -2,100 | -67.7% | 0.05% | $137K | $136.38 |
| 2024 Q1 | ADDED | 3,104 | +2,104 | +210.4% | 0.11% | $430K | $151.17 |
| 2023 Q4 | INITIATED | 1,000 | — | — | 0.04% | $126K | — |
As of 2025 Q4 — sorted by position size